Prosecution Insights
Last updated: April 19, 2026

Biovena Science LLC

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17277342 Octreotide Microsphere-Based Arterial Embolization for Treating Obesity MITCHELL, EDWIN COLEMAN 1619 Final Rejection Mar 18, 2021
17277400 Flutamide Microsphere-Based Arterial Embolization for Treating Prostate Disorders AL-AWADI, DANAH J 1615 Final Rejection Mar 18, 2021

Managing Biovena Science LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month